Review Article

Vitamin D supplementation and body fat mass: a systematic review and meta-analysis

Received:
Revised:
Accepted:
Published online:

Abstract

Studies have indicated that 25-hydroxyvitamin D (25(OH)D) level in obese is lower than normal weight subjects; however, results of studies that investigated relationship between 25(OH)D and fat mass are inconsistent. In addition, several randomized clinical trials (RCTs) have studied the influence of cholecalciferol supplement on percentage fat mass (PFM) but their results are conflicting. The objectives were to investigate the association between vitamin D3 and PFM pooling together observational studies and RCTs. PubMed/MEDLINE, Cochrane, and Scopus were comprehensively searched from inception to September 2016. The Fisher’s Z (SE) of correlation coefficient and mean (SD) of changes in PFM from baseline were used to perform meta-analysis in observational studies and RCTs, respectively. To determine potential source of heterogeneity, subgroup and meta-regression analyses were conducted. Pooling correlation coefficients showed an inverse association between PFM (Fisher’s Z: − 0.24, 95% CI: − 0.30 to −0 .18) and FM (Fisher’s Z: − 0.32, 95% CI: − 0.43 to − 0.22) and 25(OH)D. Subgroup analysis revealed continent but not gender influence on the effect size. Meta-regression analysis indicated that age, latitude, and longitude are not sources of heterogeneity. Combining trials showed vitamin D3 supplementation had a mild but insignificant effect on PFM (− 0.31%, 95% CI: − 1.07 to 0.44). Subgroup analyses indicated that type of cholecalciferol and treatment regimens explain source of heterogeneity. Age, baseline body mass index, dose of cholecalciferol, length of study, female (%), and baseline 25(OH)D are not source of heterogeneity. In conclusion, our results state that 25(OH)D level is inversely correlated with PFM but cholecalciferol supplementation had no effect on PFM.

  • Subscribe to European Journal of Clinical Nutrition for full access:

    $543

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    Cassity EP, Redzic M, Teager CR, Thomas DT. The effect of body composition and BMI on 25(OH)D response in vitamin D-supplemented athletes. Eur J Sport Sci. 2016;16:773–9.

  2. 2.

    Hazell TJ, Gallo S, Vanstone CA, Agellon S, Rodd C, Weiler HA. Vitamin D supplementation trial in infancy: body composition effects at 3 years of age in a prospective follow-up study from Montreal. Pediatr Obes. 2016;12:38–47.

  3. 3.

    Mason C, Tapsoba JD, Duggan C, Imayama I, Wang CY, Korde L, et al. Effects of vitamin D3 supplementation on lean mass, muscle strength, and bone mineral density during weight loss: a double-blind randomized controlled trial. J Am Geriatr Soc. 2016;64:769–78.

  4. 4.

    Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab. 2005;90:4119–23.

  5. 5.

    Ji L, Gupta M, Feldman BJ. Vitamin D regulates fatty acid composition in subcutaneous adipose tissue through Elovl3. Endocrinology. 2016;157:91–97.

  6. 6.

    Vilarrasa N, Vendrell J, Maravall J, Elio I, Solano E, San Jose P, et al. Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine. 2010;38:235–42.

  7. 7.

    Rahman SA, Chee WS, Yassin Z, Chan SP. Vitamin D status among postmenopausal Malaysian women. Asia Pac J Clin Nutr. 2004;13:255–60.

  8. 8.

    Kozakowski J, Kapuscinska R, Zgliczynski W. Associations of vitamin D concentration with metabolic and hormonal indices in women with polycystic ovary syndrome presenting abdominal and gynoidal type of obesity. Ginekol Pol. 2014;85:765–70.

  9. 9.

    Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003;88:157–61.

  10. 10.

    Bhatt SP, Misra A, Sharma M, Guleria R, Pandey RM, Luthra K, et al. Vitamin D insufficiency is associated with abdominal obesity in urban Asian Indians without diabetes in North India. Diabetes Technol Ther. 2014;16:392–7.

  11. 11.

    Forney LA, Earnest CP, Henagan TM, Johnson LE, Castleberry TJ, Stewart LK. Vitamin D status, body composition, and fitness measures in college-aged students. J Strength Cond Res. 2014;28:814–24.

  12. 12.

    Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J, et al. Vitamin D(3) in fat tissue. Endocrine. 2008;33:90–94.

  13. 13.

    Golzarand M, Shab-Bidar S, Koochakpoor G, Speakman JR, Djafarian K. Effect of vitamin D3 supplementation on blood pressure in adults: an updated meta-analysis. Nutr Metab Cardiovasc Dis. 2016;26:663–73.

  14. 14.

    Ghergherehchi R, Tabrizi A. Vitamin D deficiency and secondary hyperparathyroidism in pediatrics obesity. Casp J Intern Med. 2010;1:119–27.

  15. 15.

    Drincic AT, Armas LAG, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity. 2012;20:1444–8.

  16. 16.

    Jones SK, Koh GY, Rowling MJ, Schalinske KL. Whole egg consumption prevents diminished serum 25-hydroxycholecalciferol concentrations in type 2 diabetic rats. J Agric Food Chem. 2016;64:120–4.

  17. 17.

    Flodin L, Cederholm T, Saaf M, Samnegard E, Ekstrom W, Al-Ani AN, et al. Effects of protein-rich nutritional supplementation and bisphosphonates on body composition, handgrip strength and health-related quality of life after hip fracture: a 12-month randomized controlled study. BMC Geriatr. 2015;15:149.

  18. 18.

    Nelson ML, Blum JM, Hollis BW, Rosen C, Sullivan SS. Supplements of 20 μg/d cholecalciferol optimized serum 25-hydroxyvitamin D concentrations in 80% of premenopausal women in winter. J Nutr. 2009;139:540–6.

  19. 19.

    Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, Kalayi A, et al. Daily consumption of vitamin D- or vitamin D+calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr. 2011;93:764–71.

  20. 20.

    Sneve M, Figenschau Y, Jorde R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol. 2008;159:675–84.

  21. 21.

    Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, Gharavi A, et al. Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med. 2011;9:125.

  22. 22.

    Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.

  23. 23.

    Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.

  24. 24.

    Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000. p. (http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp).

  25. 25.

    Egger M, Davey-Smith G, Altman D. Systematic reviews in health care: meta-analysis in context. London, UK: John Wiley & Sons; 2008.

  26. 26.

    Higgins J, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses [journal article as teaching resource, deposited by John Flynn]. Br Med J. 2003;327:557–60.

  27. 27.

    Fractional polynomials. Available at: https://wwwstatacom/features/overview/fractional-polynomials/

  28. 28.

    Tobias A. Assessing the influence of a single study in the meta-anyalysis estimate. Stata Technical Bulletin. 1999;8:sbe26

  29. 29.

    Abdelkarem HM, El-Sherif MA, Gomaa SB. Vitamin D status and insulin resistance among young obese Saudi females. Saudi Med J. 2016;37:561–6.

  30. 30.

    Agbaht K, Mercan Y, Kutlu S, Alpdemir MF, Sezgin T. Obesity with and without metabolic syndrome: Do vitamin D and thyroid autoimmunity have a role? Diabetes Res Clin Pract. 2014;106:27–34.

  31. 31.

    Bolland MJ, Grey AB, Ames RW, Mason BH, Horne AM, Gamble GD, et al. Determinants of vitamin D status in older men living in a subtropical climate. Osteoporos Int. 2006;17:1742–8.

  32. 32.

    Boot AM, Krenning EP, de Muinck, Keizer-Schrama SM. The relation between 25-hydroxyvitamin D with peak bone mineral density and body composition in healthy young adults. J Pediatr Endocrinol Metab. 2011;24:355–60.

  33. 33.

    Fitzgerald JS, Peterson BJ, Wilson PB, Rhodes GS, Ingraham SJ. Vitamin D status is associated with adiposity in male ice hockey players. Med Sci Sports Exerc. 2015;47:655–61.

  34. 34.

    Hao Y, Ma X, Shen Y, Ni J, Luo Y, Xiao Y, et al. Associations of serum 25-hydroxyvitamin D3 levels with visceral adipose tissue in Chinese men with normal glucose tolerance. PLoS One. 2014;9:e86773.

  35. 35.

    Heller JE, Thomas JJ, Hollis BW, Larson-Meyer DE. Relation between vitamin D status and body composition in collegiate athletes. Int J Sport Nutr Exerc Metab. 2015;25:128–35.

  36. 36.

    Kerley CP, Hutchinson K, Bolger K, McGowan A, Faul J, Cormican L. Serum vitamin D is significantly inversely associated with disease severity in Caucasian adults with obstructive sleep apnea syndrome. Sleep. 2016;39:293–300.

  37. 37.

    Kim D, Kim J. Association between serum 25-hydroxyvitamin D levels and adiposity measurements in the general Korean population. Nutr Res Pract. 2016;10:206–11.

  38. 38.

    McKinney K, Breitkopf CR, Berenson AB. Association of race, body fat and season with vitamin D status among young women: A cross-sectional study. Clin Endocrinol (Oxf). 2008;69:535–41.

  39. 39.

    Palacios C, Gil K, Perez CM, Joshipura K. Determinants of vitamin D status among overweight and obese Puerto Rican adults. Ann Nutr Metab. 2012;60:35–43.

  40. 40.

    Shantavasinkul PC, Phanachet P, Puchaiwattananon O, Chailurkit LO, Lepananon T, Chanprasertyotin S, et al. Vitamin D status is a determinant of skeletal muscle mass in obesity according to body fat percentage. Nutrition. 2015;31:801–6.

  41. 41.

    Stokic E, Kupusinac A, Tomic-Naglic D, Zavisic BK, Mitrovic M, Smiljenic D, et al. Obesity and vitamin D deficiency: trends to promote a more proatherogenic cardiometabolic risk profile. Angiology. 2015;66:237–43.

  42. 42.

    Ter Horst KW, Versteeg RI, Gilijamse PW, Ackermans MT, Heijboer AC, Romijn JA, et al. The vitamin D metabolites 25(OH)D and 1,25(OH)2D are not related to either glucose metabolism or insulin action in obese women. Diabetes Metab. 2016;42:416–23. Epub ahead of print

  43. 43.

    Vilarrasa N, Maravall J, Estepa A, Sanchez R, Masdevall C, Navarro MA, et al. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest. 2007;30:653–8.

  44. 44.

    Zhang M, Li P, Zhu Y, Chang H, Wang X, Liu W, et al. Higher visceral fat area increases the risk of vitamin D insufficiency and deficiency in Chinese adults. Nutr Metab. 2015;12:50.

  45. 45.

    Zhang Y, Zhang X, Wang F, Zhang W, Wang C, Yu C, et al. The relationship between obesity indices and serum vitamin D levels in Chinese adults from urban settings. Asia Pac J Clin Nutr. 2016;25:333–9.

  46. 46.

    Bolland MJ, Grey AB, Ames RW, Horne AM, Gamble GD, Reid IR. Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. Bone. 2006;38:317–21.

  47. 47.

    Frost M, Abrahamsen B, Nielsen TL, Hagen C, Andersen M, Brixen K. Vitamin D status and PTH in young men: a cross-sectional study on associations with bone mineral density, body composition and glucose metabolism. Clin Endocrinol (Oxf). 2010;73:573–80.

  48. 48.

    Gomez JM, Maravall FJ, Gomez N, Navarro MA, Casamitjana R, Soler J. Relationship between 25-(OH) D3, the IGF-I system, leptin, anthropometric and body composition variables in a healthy, randomly selected population. Horm Metab Res. 2004;36:48–53.

  49. 49.

    Kremer R, Campbell PP, Reinhardt T, Gilsanz V. Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab. 2009;94:67–73.

  50. 50.

    Moschonis G, Tanagra S, Koutsikas K, Nikolaidou A, Androutsos O, Manios Y. Association between serum 25-hydroxyvitamin D levels and body composition in postmenopausal women: the Postmenopausal Health Study. Menopause (New Y, NY). 2009;16:701–7.

  51. 51.

    Sadiya A, Ahmed SM, Skaria S, Abusnana S. Vitamin D status and its relationship with metabolic markers in persons with obesity and type 2 diabetes in the UAE: a cross-sectional study. J Diabetes Res. 2014;2014:869307.

  52. 52.

    Tosunbayraktar G, Bas M, Kut A, Buyukkaragoz AH. Low serum 25(OH)D levels are associated to higher BMI and metabolic syndrome parameters in adult subjects in Turkey. Afr Health Sci. 2015;15:1161–9.

  53. 53.

    Nimitphong H, Chailurkit LO, Chanprasertyothin S, Sritara P, Ongphiphadhanakul B. The Association of vitamin D status and fasting glucose according to body fat mass in young healthy Thais. BMC Endocr Disord. 2013;13:60.

  54. 54.

    Obispo Entrenas A, Martín Carvajal F, Legupín Tubío D, Lucena Navarro F, García Caballero M, Gándara Adán N, et al. 5-hydroxy vitamin D and syndrome metabolic components in candidates to bariatric surgery. Nutr Hosp. 2016;33:43–46.

  55. 55.

    Caron-Jobin M, Morisset AS, Tremblay A, Huot C, Legare D, Tchernof A. Elevated serum 25(OH)D concentrations, vitamin D, and calcium intakes are associated with reduced adipocyte size in women. Obesity (Silver Spring, Md). 2011;19:1335–41.

  56. 56.

    Dasarathy J, Periyalwar P, Allampati S, Bhinder V, Hawkins C, Brandt P, et al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int. 2014;34:e118–127.

  57. 57.

    George JA, Micklesfield LK, Norris SA, Crowther NJ. The association between body composition, 25(OH)D, and PTH and bone mineral density in black african and asian indian population groups. J Clin Endocrinol Metab. 2014;99:2146–54.

  58. 58.

    Ghavamzadeh S, Mobasseri M, Mahdavi R. The effect of vitamin D supplementation on adiposity, blood glycated hemoglobin, serum leptin and tumor necrosis factor-alpha in type 2 diabetic patients. Int J Prev Med. 2014;5:1091–8.

  59. 59.

    Salehpour A, Hosseinpanah F, Shidfar F, Vafa M, Razaghi M, Dehghani S, et al. A 12-week double-blind randomized clinical trial of vitamin D3 supplementation on body fat mass in healthy overweight and obese women. Nutr J. 2012;11:78.

  60. 60.

    Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009;89:1321–7.

  61. 61.

    Sadiya A, Ahmed SM, Carlsson M, Tesfa Y, George M, Ali SH, et al. Vitamin D3 supplementation and body composition in persons with obesity and type 2 diabetes in the UAE: A randomized controlled double-blinded clinical trial. Clin Nutr. 2016;35:77–82.

  62. 62.

    Cangussu LM, Nahas-Neto J, Orsatti CL, Bueloni-Dias FN, Nahas EAP. Effect of vitamin D supplementation alone on muscle function in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial. Osteoporos Int. 2015;26:2413–21.

  63. 63.

    Wamberg L, Kampmann U, Stodkilde-Jorgensen H, Rejnmark L, Pedersen SB, Richelsen B. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial. Eur J Intern Med. 2013;24:644–9.

  64. 64.

    Song Q, Sergeev IN. Calcium and vitamin D in obesity. Nutr Res Rev. 2012;25:130–41.

  65. 65.

    Soares M, Ping-Delfos WCS, Ghanbari M. Calcium and vitamin D for obesity: a review of randomized controlled trials. Eur J Clin Nutr. 2011;65:994–1004.

  66. 66.

    Pannu PK, Zhao Y, Soares MJ. Reductions in body weight and percent fat mass increase the vitamin D status of obese subjects: a systematic review and metaregression analysis. Nutr Res (New Y, NY). 2016;36:201–13.

  67. 67.

    Mallard SR, Howe AS, Houghton LA. Vitamin D status and weight loss: a systematic review and meta-analysis of randomized and nonrandomized controlled weight-loss trials. Am J Clin Nutr. 2016;104:1151–9.

  68. 68.

    Renzaho AM, Halliday JA, Nowson C. Vitamin D, obesity, and obesity-related chronic disease among ethnic minorities: a systematic review. Nutrition. 2011;27:868–79.

  69. 69.

    Saneei P, Salehi‐Abargouei A, Esmaillzadeh A. Serum 25‐hydroxy vitamin D levels in relation to body mass index: a systematic review and meta‐analysis. Obes Rev. 2013;14:393–404.

  70. 70.

    Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013;10:e1001383.

  71. 71.

    Collaboration PS. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96.

  72. 72.

    Allison DB, Faith MS, Heo M, Kotler DP. Hypothesis concerning the U-shaped relation between body mass index and mortality. Am J Epidemiol. 1997;146:339–49.

  73. 73.

    Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003;88:157–61.

  74. 74.

    Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab. 2005;90:4119–23.

  75. 75.

    Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care. 2001;4:499–502.

  76. 76.

    Lee S, Kuk JL, Hannon TS, Arslanian SA. Race and gender differences in the relationships between anthropometrics and abdominal fat in youth. Obesity. 2008;16:1066–71.

  77. 77.

    Bacha F, Saad R, Gungor N, Janosky J, Arslanian SA. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab. 2003;88:2534–40.

  78. 78.

    Looker AC. Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metab. 2005;90:635–40.

  79. 79.

    Rajakumar K, de Las Heras J, Chen TC, Lee S, Holick MF, Arslanian SA. Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab. 2011;96:1560–7.

  80. 80.

    Florez H, Martinez R, Chacra W, Strickman-Stein N, Levis S. Outdoor exercise reduces the risk of hypovitaminosis D in the obese. J Steroid Biochem Mol Biol. 2007;103:679–81.

  81. 81.

    Alemzadeh R, Kichler J, Babar G, Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism. 2008;57:183–91.

  82. 82.

    Harris SS, Dawson-Hughes B. Reduced sun exposure does not explain the inverse association of 25-hydroxyvitamin D with percent body fat in older adults. J Clin Endocrinol Metab. 2007;92:3155–7.

  83. 83.

    Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690–3.

  84. 84.

    Pathak K, Soares MJ, Calton EK, Zhao Y, Hallett J. Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2014;15:528–37.

  85. 85.

    Shahar DR, Schwarzfuchs D, Fraser D, Vardi H, Thiery J, Fiedler GM, et al. Dairy calcium intake, serum vitamin D, and successful weight loss. Am J Clin Nutr. 2010;92:1017–22.

  86. 86.

    Ortega RM, Aparicio A, Rodríguez-Rodríguez E, Bermejo LM, Perea JM, López-Sobaler AM, et al. Preliminary data about the influence of vitamin D status on the loss of body fat in young overweight/obese women following two types of hypocaloric diet. Br J Nutr. 2008;100:269–72.

  87. 87.

    Forouhi NG, Ja Luan, Cooper, Boucher A, Wareham BJ, Baseline NJ. serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance the medical research council ely prospective study 1990–2000. Diabetes. 2008;57:2619–25.

  88. 88.

    Zemel MB, Thompson W, Milstead A, Morris K, Campbell P. Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res. 2004;12:582–90.

Download references

Author information

Affiliations

  1. Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    • Mahdieh Golzarand
    •  & Parvin Mirmiran
  2. Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    • Mahdieh Golzarand
    •  & Parvin Mirmiran
  3. Division of Neonatology, Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA

    • Bruce W. Hollis
    •  & Carol L. Wagner
  4. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran

    • Sakineh Shab-Bidar

Authors

  1. Search for Mahdieh Golzarand in:

  2. Search for Bruce W. Hollis in:

  3. Search for Parvin Mirmiran in:

  4. Search for Carol L. Wagner in:

  5. Search for Sakineh Shab-Bidar in:

Conflict of interest

The authors declare that they have no conflict of interest.

Corresponding author

Correspondence to Sakineh Shab-Bidar.

Electronic supplementary material